NCR1 antibody (AA 121-230) (HRP)

Catalog No. ABIN7161074

This Rabbit Polyclonal antibody specifically detects NCR1 in ELISA. It exhibits reactivity toward Human.

Quick Overview for NCR1 antibody (AA 121-230) (HRP) (ABIN7161074)

Target: NCR1 (Natural Cytotoxicity Triggering Receptor 1 (NCR1))

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This NCR1 antibody is conjugated to HRP

Application: ELISA

Product Details anti-NCR1 Antibody (HRP)

Binding Specificity: AA 121-230

Cross-Reactivity: Human

Purification: >95%, Protein G purified

Immunogen: Recombinant Human Natural cytotoxicity triggering receptor 1 protein (121-230AA)

Isotype: IgG

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C,-80 °C

Storage Comment: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Target Details for NCR1

Target: NCR1 (Natural Cytotoxicity Triggering Receptor 1 (NCR1))

Alternative Name: NCR1

Background:

Background: Cytotoxicity-activating receptor that may contribute to the increased efficiency of activated natural killer (NK) cells to mediate tumor cell lysis.

Aliases: Activating NK receptor NK p46 antibody, CD335 antibody, FLJ99094 antibody, hNKp46 antibody, Ly94 antibody, Lymphocyte antigen 94 antibody, Lymphocyte antigen 94 homolog (activating NK receptor, NK p46) antibody, Lymphocyte antigen 94 homolog antibody, Natural cytotoxicity triggering receptor 1 antibody, Natural killer cell p46-related protein antibody, NCR1 antibody, NCT1 antibody, NCTR1_HUMAN antibody, NK cell activating receptor antibody, NK cell-activating receptor antibody, NK-p46 antibody, NKp46 antibody

UniProt: O76036

Pathways: Regulation of Leukocyte Mediated Immunity